Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Testing Materials

    PPMI Dispatch: The Study Enters a New Phase

    The study completed enrollment and met the ambitious goal of enrolling 1,400 participants, including 600 with rare genetic mutations.
    Learn more

  • Researcher-computer

    Harnessing AI for Parkinson's Research

    MJFF and IBM announced a partnership using artificial intelligence to develop a model for Parkinson's.
    Learn more

  • 2018 in Review Research Progress

    2018 in Review, 2019 in Focus

    Read highlights and download our 2018 in Review/2019 in Focus booklet.
    Learn more

  • Researchers talking with patients

    Parkinson's Inosine Trial Ending Early

    An interim analysis concluded that the SURE-PD3 trial is unlikely to determine that inosine can slow Parkinson's progression. The trial therefore is ending earlier than planned.
    Learn more

  • Research Testing

    Alkahest Begins Phase II Trial of Plasma-Based Therapy

    As we age, the quality of our plasma and its proteins can degrade, which may contribute to problems that damage our brain cells and affect cognition.
    Learn more

  • Fox Insight logo

    Fox Insight Brings Patient Perspective to Parkinson's Drug Development

    At a meeting with the FDA, patients, researchers, clinicians, drug makers and nonprofits, MJFF discussed Fox Insight and the role of technology in drug development to help capture patient…
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.